Silica particles can cause new treatments for obesity and diabetes, Trap absorption of molecules made by intestinal mesoporous silica (MSPs) particles can affect nutritional efficiency and metabolic risk factors.
The results of studies in mice indicate the potential to reduce energy intake and can lead to new therapies for obesity and diabetes.
So far, there is no effective obesity treatment that prevents weight gain or promotes weight loss without problematic side effects. Many drugs today use small pharmacological agents that can negatively affect the body in various ways. We have chosen an innovative alternative approach. Mesoporous silica particles (MSP) are an acceptable type of synthetic silica particles that can be made with a large surface area and various pore sizes. One researcher said the new silica particles can cause new treatments for obesity and diabetes.
The team suggests that particles can be used as “molecular sieves” in the intestine to capture and block digestive enzymes that break down food, thereby reducing energy consumption (measured as nutrient efficiency). Rats were given a high-calorie high-content diet, to induce weight gain mixed with a specially developed MSP. The results show that MSP reduces food efficiency by 33 percent, which leads to lower weight gain and a positive effect on metabolic profile and significantly lower fat and leptin formation along with lower amounts. circulating insulin.
The data presented in this study shows that adjusted SMEs can be used to treat obesity and diabetes in humans, especially given their excellent safety profile. After this work is complete, clinical trials have been developed and are ongoing, Researchr said.